vs
Side-by-side financial comparison of CoastalSouth Bancshares, Inc. (COSO) and FENNEC PHARMACEUTICALS INC. (FENC). Click either name above to swap in a different company.
CoastalSouth Bancshares, Inc. is the larger business by last-quarter revenue ($21.3M vs $13.8M, roughly 1.5× FENNEC PHARMACEUTICALS INC.). CoastalSouth Bancshares, Inc. runs the higher net margin — 31.7% vs -34.7%, a 66.4% gap on every dollar of revenue.
CoastalSouth Bancshares, Inc. is a U.S.-based regional bank holding company. It provides a full range of personal and commercial banking services including deposit accounts, consumer loans, mortgages, commercial financing and wealth management solutions for retail customers and small-to-medium enterprises across the U.S. Gulf Coast region.
Fennec Pharmaceuticals Inc. is a biopharmaceutical firm focused on developing and commercializing therapies to reduce treatment-related side effects in pediatric cancer patients. Its lead product targets chemotherapy-induced ototoxicity, with core North American markets serving oncology providers and vulnerable pediatric patient groups.
COSO vs FENC — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $21.3M | $13.8M |
| Net Profit | $6.7M | $-4.8M |
| Gross Margin | — | — |
| Operating Margin | 41.2% | -18.5% |
| Net Margin | 31.7% | -34.7% |
| Revenue YoY | — | 73.8% |
| Net Profit YoY | — | -141.1% |
| EPS (diluted) | $0.54 | $-0.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $13.8M | ||
| Q3 25 | $21.3M | $12.5M | ||
| Q2 25 | $19.9M | $9.7M | ||
| Q1 25 | — | $8.8M | ||
| Q4 24 | — | $7.9M | ||
| Q3 24 | — | $7.0M | ||
| Q2 24 | — | $7.3M | ||
| Q1 24 | — | $25.4M |
| Q4 25 | — | $-4.8M | ||
| Q3 25 | $6.7M | $-638.0K | ||
| Q2 25 | $6.0M | $-3.2M | ||
| Q1 25 | — | $-1.2M | ||
| Q4 24 | — | $-2.0M | ||
| Q3 24 | — | $-5.7M | ||
| Q2 24 | — | $-5.6M | ||
| Q1 24 | — | $12.8M |
| Q4 25 | — | -18.5% | ||
| Q3 25 | 41.2% | -1.5% | ||
| Q2 25 | 35.4% | -28.3% | ||
| Q1 25 | — | -9.2% | ||
| Q4 24 | — | -11.8% | ||
| Q3 24 | — | -74.6% | ||
| Q2 24 | — | -69.4% | ||
| Q1 24 | — | 54.2% |
| Q4 25 | — | -34.7% | ||
| Q3 25 | 31.7% | -5.1% | ||
| Q2 25 | 30.0% | -32.7% | ||
| Q1 25 | — | -13.3% | ||
| Q4 24 | — | -25.0% | ||
| Q3 24 | — | -82.2% | ||
| Q2 24 | — | -76.5% | ||
| Q1 24 | — | 50.6% |
| Q4 25 | — | $-0.17 | ||
| Q3 25 | $0.54 | $-0.02 | ||
| Q2 25 | $0.57 | $-0.11 | ||
| Q1 25 | — | $-0.04 | ||
| Q4 24 | — | $-0.02 | ||
| Q3 24 | — | $-0.21 | ||
| Q2 24 | — | $-0.20 | ||
| Q1 24 | — | $0.41 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $36.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $250.4M | $35.5M |
| Total Assets | $2.3B | $70.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $36.8M | ||
| Q3 25 | — | $21.9M | ||
| Q2 25 | — | $18.7M | ||
| Q1 25 | — | $22.7M | ||
| Q4 24 | — | $26.6M | ||
| Q3 24 | — | $40.3M | ||
| Q2 24 | — | $43.1M | ||
| Q1 24 | — | $51.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | $19.4M | ||
| Q2 25 | — | $19.4M | ||
| Q1 25 | — | $19.4M | ||
| Q4 24 | — | $19.3M | ||
| Q3 24 | — | $32.1M | ||
| Q2 24 | — | $31.8M | ||
| Q1 24 | — | $31.3M |
| Q4 25 | — | $35.5M | ||
| Q3 25 | $250.4M | $-4.5M | ||
| Q2 25 | $209.4M | $-7.5M | ||
| Q1 25 | — | $-5.9M | ||
| Q4 24 | — | $-5.9M | ||
| Q3 24 | — | $-5.2M | ||
| Q2 24 | — | $-1.4M | ||
| Q1 24 | — | $3.0M |
| Q4 25 | — | $70.6M | ||
| Q3 25 | $2.3B | $49.3M | ||
| Q2 25 | $2.2B | $44.9M | ||
| Q1 25 | — | $46.4M | ||
| Q4 24 | — | $44.9M | ||
| Q3 24 | — | $58.9M | ||
| Q2 24 | — | $63.2M | ||
| Q1 24 | — | $69.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 10.40× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-5.5M | $-6.0M |
| Free Cash FlowOCF − Capex | $-5.9M | — |
| FCF MarginFCF / Revenue | -27.7% | — |
| Capex IntensityCapex / Revenue | 1.9% | — |
| Cash ConversionOCF / Net Profit | -0.82× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-6.0M | ||
| Q3 25 | $-5.5M | $1.5M | ||
| Q2 25 | $-16.8M | $-3.7M | ||
| Q1 25 | — | $-4.3M | ||
| Q4 24 | — | $-1.5M | ||
| Q3 24 | — | $-2.2M | ||
| Q2 24 | — | $-8.4M | ||
| Q1 24 | — | $39.0M |
| Q4 25 | — | — | ||
| Q3 25 | $-5.9M | — | ||
| Q2 25 | $-17.9M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | -27.7% | — | ||
| Q2 25 | -90.3% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 1.9% | — | ||
| Q2 25 | 5.5% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | -0.82× | — | ||
| Q2 25 | -2.82× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 3.04× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
